Radiology

How Late Iodine Enhancement CT Solves Troponin Dilemmas

Published on Oct 16, 2026
3 min read
How Late Iodine Enhancement CT Solves Troponin Dilemmas - OC Academy Medical Insights
"Discover how late iodine enhancement CT refines diagnoses and guides clinical care in patients with acute cardiac chest pain and elevated troponin levels."

How Late Iodine Enhancement CT Solves Troponin Dilemmas

Emergency physicians frequently encounter patients with acute chest pain and elevated high-sensitivity troponin who lack classic myocardial infarction criteria. In these challenging scenarios, comprehensive late iodine enhancement CT offers a transformative diagnostic solution. Traditional coronary CT angiography primarily rules out obstructive epicardial disease. However, incorporating late iodine enhancement and extracellular volume fraction allows physicians to evaluate myocardial tissue damage directly. Consequently, clinicians can achieve a rapid and accurate diagnosis within the emergency department.

Value of Late Iodine Enhancement CT in the Emergency Department

A prospective investigation examined 191 consecutive patients presenting with acute symptoms and elevated troponin levels. Notably, researchers excluded individuals with prior coronary revascularization to assess native disease accurately. Patients initially underwent coronary CT angiography to rule out significant stenosis of 50 percent or greater. Subsequently, individuals without obstructive coronary disease underwent myocardial tissue characterization using late iodine enhancement. In addition, specialists quantified extracellular volume when initial scans appeared negative. Therefore, this structured protocol addressed both vascular and myocardial pathologies in a single examination.

Diagnostic Accuracy and Etiological Insights

The study protocol revealed remarkable diagnostic capability. Specifically, coronary angiography identified obstructive coronary artery disease in 40 percent of the cohort. Furthermore, late iodine enhancement and extracellular volume imaging yielded positive findings in 55 percent of coronary-negative patients. These myocardial scans uncovered myocarditis in 30 percent and Takotsubo cardiomyopathy in 13 percent of cases. Additionally, imaging detected acute infarction with non-obstructive arteries in 8 percent, amyloidosis in 3 percent, and dilated cardiomyopathy in 1 percent. Most importantly, the comprehensive scan modified the working clinical diagnosis in 48 percent of all patients. Thus, CT findings showed exceptional agreement with final discharge diagnoses at 0.94.

Clinical Implications and Patient Safety

These findings carry substantial clinical relevance for emergency triage. For instance, rapid tissue characterization reduces the need for expensive downstream cardiac magnetic resonance imaging. Moreover, the protocol established outstanding mid-term prognostic safety. Among the 25 percent of patients with completely negative imaging, no major adverse cardiovascular events occurred over a 24-month follow-up period. Hence, physicians can safely reassure and discharge patients who show normal scans. Ultimately, adopting this comprehensive imaging pathway expedites targeted therapies while avoiding unnecessary invasive procedures.

Frequently Asked Questions

Q1: What is the main benefit of adding late iodine enhancement to cardiac CT?

It enables direct myocardial tissue characterization, allowing clinicians to diagnose myocarditis, Takotsubo cardiomyopathy, and infarction with non-obstructive coronary arteries in one sitting.

Q2: How does a completely negative CT scan impact long-term patient prognosis?

Patients with negative findings on coronary angiography and late enhancement experienced zero major adverse cardiovascular events during a 24-month median follow-up.

Q3: Can this protocol change initial management in the emergency room?

Yes, the dual assessment altered the working clinical diagnosis in 48 percent of patients, ensuring timely and appropriate medical therapy.

References

  1. Vignale D et al. The role of cardiac CT with late iodine enhancement in patients with acute cardiac symptoms and troponin elevation in the era of high-sensitivity assays. Eur Radiol. 2026 Oct 15. doi: 10.1007/s00330-026-12967-w. PMID: 42878809.
  2. Esposito A, Palmisano A, Barbera M, et al. Cardiac Computed Tomography in Troponin-Positive Chest Pain: Sometimes the Answer Lies in the Late Iodine Enhancement or Extracellular Volume Fraction Map. JACC Cardiovasc Imaging. 2019;12(4):745-748.
  3. Palmisano A, Vignale D, Turchio P, et al. Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome. Radiology. 2022;302(3):545-553.

Related Articles You May Like